home / stock / fstx / fstx short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,415,494 |
Total Actual Volume | 10,485,802 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 11 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 70,775 |
Average Short Percentage | 44.31% |
Is there a FSTX Short Squeeze or Breakout about to happen?
See the FSTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-23 | 6.66 | 6.36 | 6.66 | 6.12 | 7,504,580 | 916,650 | 51.7643 |
2022-06-22 | 3.56 | 3.98 | 4.08 | 3.56 | 519,583 | 100,034 | 45.8285 |
2022-06-21 | 3.5 | 3.58 | 3.9 | 3.5 | 239,423 | 47,726 | 50.1988 |
2022-06-16 | 3.24 | 3.26 | 3.56 | 3.044 | 242,407 | 14,882 | 18.8899 |
2022-06-15 | 3.51 | 3.37 | 3.83 | 3.37 | 385,775 | 8,377 | 2.6035 |
2022-06-14 | 3.42 | 3.47 | 3.58 | 3.361 | 48,408 | 8,979 | 61.5844 |
2022-06-13 | 3.43 | 3.4 | 3.52 | 3.29 | 82,267 | 6,142 | 18.1062 |
2022-06-09 | 4.06 | 3.85 | 4.06 | 3.7244 | 109,815 | 14,257 | 40.3173 |
2022-06-08 | 3.5 | 4.01 | 4.1 | 3.43 | 213,430 | 42,871 | 51.6188 |
2022-06-06 | 3.3 | 3.5 | 3.87 | 3.3 | 368,837 | 63,926 | 52.2391 |
2022-06-03 | 2.9 | 3.27 | 3.27 | 2.87 | 134,494 | 37,874 | 54.4997 |
2022-06-02 | 2.81 | 2.84 | 2.92 | 2.77 | 31,418 | 11,534 | 61.6890 |
2022-06-01 | 3.04 | 2.79 | 3.085 | 2.75 | 100,377 | 16,247 | 27.3874 |
2022-05-31 | 2.87 | 3.04 | 3.06 | 2.84 | 99,738 | 34,469 | 65.2328 |
2022-05-26 | 2.59 | 2.54 | 2.6636 | 2.51 | 126,937 | 25,686 | 39.6799 |
2022-05-25 | 2.53 | 2.62 | 2.65 | 2.53 | 19,470 | 2,151 | 27.7226 |
2022-05-24 | 2.83 | 2.57 | 2.83 | 2.52 | 41,429 | 10,512 | 79.6545 |
2022-05-23 | 2.5276 | 2.74 | 2.7694 | 2.5 | 65,656 | 20,615 | 55.3899 |
2022-05-19 | 2.38 | 2.56 | 2.57 | 2.38 | 48,198 | 8,857 | 28.9274 |
2022-05-18 | 2.4 | 2.38 | 2.53 | 2.26 | 103,560 | 23,705 | 52.9295 |
F-star Therapeutics Inc Com Company Name:
FSTX Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Proposed ~US$161 million all-cash acquisition to accelerate invoX’s strategy to build Sino Biopharm’s International Biopharmaceutical R&D Platform outside of China, transforming the lives of patients worldwide The transaction demonstrates the strength of F-st...
Four Clinical Readouts Anticipated Throughout 2022 Mechanistic Data on FS118 Demonstrating Shedding Mechanism and LAG-3 Reduction Presented at the 2022 American Association for Cancer Research (AACR) Annual Meeting Company To Host Conference Call Today at 9...
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced t...